PPIA is a novel adipogenic factor implicated in obesity

Area of Science:

• Biochemistry
• Molecular Biology
• Metabolic Research

Background:

• Adipogenesis, the process of fat cell differentiation, is crucial for energy homeostasis.
• Obesity is a complex metabolic disorder linked to excessive adiposity.
• The molecular mechanisms regulating adipogenesis and obesity require further elucidation.

Purpose of the Study:

• To investigate the function of peptidyl-prolyl cis/trans isomerase a (PPIA) in adipogenesis.
• To determine the role of PPIA in the development of obesity.

Main Methods:

• Comparative analysis of fat mass and adipocyte size in PPIA knockout and wild-type mice.
• In vitro studies using 3T3L1 cells and mouse embryonic fibroblasts (MEFs) with PPIA gene silencing and overexpression.
• Assessment of PPIA's role in high-fat diet-induced and gestational diabetes-induced obesity models.

Main Results:

• PPIA knockout mice exhibited significantly reduced fat mass and smaller adipocyte size compared to wild-type controls.
• Silencing PPIA impaired adipocyte differentiation in 3T3L1 cells and MEFs, an effect reversed by PPIA reintroduction.
• PPIA deficiency led to decreased expression of key adipogenic factors (PPARG, C/EBPA, C/EBPB) and reduced weight gain on a high-fat diet.
• Elevated PPIA expression was observed in gestational diabetes rat offspring with increased fat accumulation.

Conclusions:

• PPIA acts as a novel adipogenic factor.
• PPIA plays a significant role in the pathogenesis of obesity.